21 of these mutations resulted in the downregulation of the NECTIN4 expression, specifically in the Uterine Corpus Endometrial Carcinoma (UCEC), as illustrated in Fig 6B. This evidence concerns the gene NECTIN4 and endometrial carcinoma.